Inovio Pharma (INO) Misses Q1 EPS by 51c
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.11 -0.89%
EPS Growth %: +60.7%
Financial Fact:
License fee and milestone revenue: 2.33M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +60.7%
Financial Fact:
License fee and milestone revenue: 2.33M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q1 EPS of ($0.51).
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
- Edgewell stock surges on report of rejected takeover bid
- Boeing wins $121 million Navy contract for P-8A upgrades
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
